|
ALI convened four experts for a robust conversation on U.S.-China competition. William Hannas (Georgetown), Melanie Hart (Atlantic Council), Jimmy Goodrich (RAND Corporation), and Constanza M. Vidal Bustamante (CNAS) discussed the status of U.S.-China competition in AI, biotechnology, semiconductors and quantum.
While the U.S. maintains a narrow lead in each technology, that advantage is at risk, as the U.S. unwinds decades of federal investment in research, partnership with universities, and limits high-skilled immigration. Meanwhile, China is rapidly expanding its investment in all of these technologies, focusing on both research and implementation. China is also combining technologies, like AI, biotech, and robotics, in ways that the U.S. is not.
In China's 15th 5-year plan, President Xi wrote that China has to pursue “extreme measures” to innovate across all aspects of the supply chain, mandating that Chinese industry must see tangible success in these technologies over the next five years.
Historically, America's open innovation ecosystem has surpassed China's top-down strategy. However, given current cuts to R&D, combined with limits on high-skilled immigration, U.S. technology leadership is at risk.
|